Public Consultation on the Post-market Review of PAH medicines

Page last updated: 26 July 2017

Public Consultation addressing the Terms of Reference: 13 February to 27 March 2017 (closed)

Public consultation addressing the Review and final Terms of Reference closed on 27 March 2017.  The Department appreciates the contribution of all organisations and the individual who made a submission.

Public Consultation on the draft Terms of Reference: 2 May to 16 May 2016 (closed)

The public consultation process for the draft Terms of Reference closed on 16 May 2016. The Department appreciates the contribution of all organisations and individuals who made a submission. 

Subscribe to news updates for the latest information regarding reviews, including public consultation opportunities.

Disclaimer

  • The views expressed in submissions published on this website are solely those of the contributing authors or organisations.
  • The Commonwealth accepts no responsibility for the completeness or accuracy of any information contained in the submissions.
  • The Commonwealth makes no representations about the suitability of the information for any particular purpose. Users of the information must make their own inquiries and assessments about those matters or seek independent advice.
  • Submissions are published on the understanding that the contributing authors or organisations have copyright in the submissions either by way of ownership or a licence. They retain their copyright, and by making submissions they licence the Commonwealth to publish the submissions, unless a party when making a submission has requested that it be kept confidential and the Commonwealth clearly agrees that the submission will be kept confidential.

Privacy

Unless otherwise requested, submissions commenting on the draft Terms of Reference have been published below.

The Department of Health does not publish submissions, or parts of submissions, which contain personal information, offensive language, potentially defamatory material or copyright infringing material.

Responsibility for copyright in submissions resides with the author(s), not with the Department of Health.

All submissions have been converted to Portable Document Format (PDF) for publication and may have a different appearance to the document that was submitted.

Your submission and contact details will be stored in accordance with the Australian Privacy Principles from Schedule 1 of the Privacy Amendment (Enhancing Privacy Principles) Act 2012 and the Archives Act 2012.  Should you have any concerns about the storage of your submission, or if you wish to gain access to make a correction, please contact the PAH Review Secretariat. A copy of the Department’s privacy policy is available on request. If you wish to make a complaint about the handling of your private information, you may contact the Department of Health Privacy Contact Officer on 02 6289 5773 and, if unsatisfied with the response, you may submit a complaint to the Office of the Australian Information Commissioner.

 

Table of Submissions addressing the Terms of Reference

Submission

Author Name

Document Link

Date Received

1

Thoracic Society of Australia and New Zealand (TSANZ)

Submission 1 

21/03/2017

2

Industry Organisation

Not for Publication

29/05/2017

3

Industry Organisation

Not for Publication

27/03/2017

4

Pulmonary Hypertension Association Australia (PHA Australia)

Submission 4 

24/05/2017

5

GlaxoSmithKline Pty Ltd

Submission 5 

27/03/2017

6

Dr Kenneth Whyte

Submission 6 

28/03/2017

7

Council of Australian Therapeutic Advisory Groups (CATAG)

Submission 7 

29/05/2017

Table of Submissions addressing the draft Terms of Reference

Submission

Author Name

Document Link

Date Received

1

Pulmonary Hypertension Society of Australia and New Zealand Inc (PHSANZ)

Submission 1

13/05/2016

2

Academic / Health Professional

Not for Publication

14/05/2016

3

Individual

Not for Publication

15/05/2016

4

Individual

Not for Publication

15/05/2016

5

Actelion Pharmaceuticals Australia Pty Ltd

Submission 5

16/05/2016

6

Individual

Not for Publication

16/05/2016

7

Individual

Not for Publication

16/05/2016

8

Dr Richard Whitaker

Submission 8

16/05/2016

9

Lung Foundation Australia

Submission 9

16/05/2016

10

Individual

Not for Publication

16/05/2016

11

Individual

Not for Publication

16/05/2016

12

GlaxoSmithKline Pty Ltd

Submission 12

16/05/2016

13

PHA Australia Inc

Submission 13

16/05/2016

14

Individual

Not for Publication

16/05/2016

Top of page